FDA approves first 'breakthrough' drug that could treat up to 90% of cystic fibrosis patients

The US Food and Drug Administration has approved Trikafta, a combination of three drugs t for patients 12 years and older who have the most common genetic mutation of cystic fibrosis.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news